A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
Titel:
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
Auteur:
Li, John Y. Perry, Samuel R. Muniz-Medina, Vanessa Wang, Xinzhong Wetzel, Leslie K. Rebelatto, Marlon C. Masson Hinrichs, Mary Jane Bezabeh, Binyam Z. Fleming, Ryan L. Dimasi, Nazzareno Feng, Hui Toader, Dorin Yuan, Andy Q. Xu, Lan Lin, Jia Gao, Changshou Wu, Herren Dixit, Rakesh Osbourn, Jane K. Coats, Steven R.